Massive Real-World study tracks kidney Drug's impact on thousands
NCT ID NCT07450820
First seen Mar 11, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study looks at health records from over 14,000 people with chronic kidney disease in Spain to see how the drug dapagliflozin is used and how well it works in real life. Researchers will track changes in kidney function, hospital visits, and costs over about three years. No new treatments are given—this is just an observation of what happens in routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGMadrid, 28002, Spain
Conditions
Explore the condition pages connected to this study.